Terray Therapeutics

Thank you to Steve Lohr and The New York Times for featuring Terray Therapeutics. We’re proud to be changing the way computation and experimentation work together to generate the kind of data needed to deliver on the promise of A.I. in drug discovery to solve the toughest therapeutic challenges. As our CEO, Jacob Berlin, PhD said: “Once you have the right kind of data, the A.I. can work and get really, really good.” That is our data, and it's all pointed at a “once-in-a-century opportunity" for the pharmaceutical industry to deliver for patients in need. Thank you to our extraordinary team, our partners at Bristol Myers Squibb and Calico Life Sciences, our collaborators at NVIDIA, and all of our amazing investors including Madrona, Digitalis Ventures, Two Sigma Ventures, and KdT Ventures.   The best is ahead. Read more: https://lnkd.in/eMtyFdNQ   #generativeAI #biotech #ML #drugdiscovery

How will machine learning impact the future of drug development? What are the biggest challenges and opportunities in combining computational and experimental methods in this field? Machine learning is revolutionizing drug development by predicting protein properties and enabling the design of targeted and diverse molecules. Through chip-based experiments and computational modeling, researchers can generate vast amounts of data to optimize molecules for specific therapeutic effects. This scalable and iterative approach reduces clinical development risks by selecting molecules with higher affinity, potency, and selectivity. By combining computational and experimental methods, scientists are accelerating the discovery and optimization of new drugs, leading to more effective and efficient treatments. Check out our full session from the 2024 #MontySummit on biopharma's AI revolution with D.A. Wallach (Time BioVentures), Jacob Berlin, PhD (Terray Therapeutics), and Michael Nally (Flagship Pioneering). #MachineLearning #DrugDevelopment #Biotech #Innovation #Healthcare #AI #biopharma https://lnkd.in/gqQ82qMv

Thank you to our amazing investors and collaborators at NVIDIA for hosting us to present Terray Therapeutics to this incredible audience! #machinelearning #ml #biotech #generativeai #drugdiscovery #NVIDIA

The AWS Life Sciences Leaders Symposium is May 2nd in Boston featuring Terray Therapeutics CEO Jacob Berlin, PhD! Thank you to the entire Amazon Web Services (AWS) team for hosting us! This full-day, in-person event is designed to showcase how life sciences organizations are leveraging generative AI and machine learning, and innovations like lab-in-the-loop to reshape pharma R&D – propelling the industry forward and bringing ground-breaking therapeutics to market. More information can be found here: https://lnkd.in/dA5gR9W4 #machinelearning #ml #biotech #generativeaai #drugdiscovery #aws

Thank you to the AWS Life Sciences team for featuring Jacob Berlin, PhD as the Keynote speaker at the upcoming AWS Life Sciences Leaders Symposium on May 2nd in Boston! This full-day, in-person event is designed to showcase how life sciences organizations are leveraging generative AI and machine learning, and innovations like lab-in-the-loop to reshape pharma R&D – propelling the industry forward and bringing ground-breaking therapeutics to market. More information can be found here: https://lnkd.in/dA5gR9W4 #machinelearning #ml #biotech #generativeaai #drugdiscovery

Excited to join @Columbia Business School’s @Healthcare Mgmt Program for the second annual Columbia Business School Digital Health Summit on Friday, April 5th, 2024 at 1:00 PM ET. I will be speaking on the AI for Drug Discovery panel starting at 3:40 PM ET. Join me and other leaders and industry experts who are shaping the future of healthcare by leveraging AI, technology, and digital tools for this event. #CBSDigitalHealthSummit #2024CBSDHS #HealthcareatCBS

Fantastic interview with John Parkhill, our Director of Machine Learning, at #GTC24 discussing how our high-quality data at scale is the key to unlocking generative AI for small molecules. Thank you to all of our amazing collaborators and investors at NVIDIA for featuring Terray Therapeutics throughout the conference! #gtc24 #machinelearning #ml #biotech #generativeaai #drugdiscovery #nvidia Tony Paikeday https://lnkd.in/gdVB_aFE

Thank you to our amazing collaborators and investors at NVIDIA for featuring Terray Therapeutics across #GTC24 next week! On Monday, join our COO/CFO Eli Berlin at the “NVIDIA NVentures Portfolio Showcase,” and on Wednesday, join our Machine Learning Engineer Ryan Pederson at “BioNeMo for Generative AI in Drug Discovery” and our Director of Machine Learning John Parkhill at the “#AI Implementer Panel: Accelerating the Generative AI Transformation!” Come learn more about how we transformed the way experimentation and computation work together to build the world's largest experimental chemistry dataset (growing by 300M+ measurements a month) which powers our #generativeai to solve the toughest therapeutic challenges.  #gtc24 #machinelearning #ml #biotech #generativeai #drugdiscovery #nvidia

Thank you Evercore for hosting Jacob Berlin, PhD, CEO and Co-Founder of Terray Therapeutics at the Evercore ISI Emerging Biotech Conference 2024! Jacob's presentation detailed how we built the world's largest experimental chemistry dataset (growing by 300M+ measurements a month), and transformed the way experimentation and computation work together to solve the toughest therapeutic challenges!

Terray is proud to announce that COATI, our molecular language for Generative AI in Small Molecule Drug Discovery, is the cover article in the latest edition of the Journal of Chemical Information and Modeling. COATI, or “Contrastive Optimization for Accelerated Therapeutic Inference,” is a multimodal foundation model for small molecules, which allows us to efficiently explore chemical space by enabling conditional generation of property-optimized small molecules. To learn more: https://lnkd.in/gh9X9ccm #machinelearning #ML #biotech #generativeAI #drugdiscovery